Pacific Biosciences of California, Inc. Operating Expenses
Pacific Biosciences of California, Inc. (PACB) reported Operating Expenses of $57.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Pacific Biosciences of California, Inc. operating expenses for the quarter ending 2026-06-30 was $57.25M, a 3.84% decline year-over-year.
- Pacific Biosciences of California, Inc. operating expenses for the quarter ending 2026-03-31 was $21.20M, a 95.04% decline year-over-year.
- Pacific Biosciences of California, Inc. operating expenses for the quarter ending 2025-12-31 was $57.76M, a 64.58% decline year-over-year.
- Pacific Biosciences of California, Inc. operating expenses for the quarter ending 2025-09-30 was $54.78M, a 26.06% decline year-over-year.
- Pacific Biosciences of California, Inc. operating expenses for fiscal 2025 was $599.64M, a 17.21% increase from fiscal 2024.
- Pacific Biosciences of California, Inc. operating expenses for fiscal 2024 was $511.60M, a 32.11% increase from fiscal 2023.
- Pacific Biosciences of California, Inc. operating expenses for fiscal 2023 was $387.25M, a 8.71% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. operating expenses for fiscal 2022 was $356.23M, a 32.28% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.25M 10-Q · filed 2026-08-06 | $78.45M 10-Q · filed 2026-08-06 | $136.21M derived: sum of 3 quarters · filed 2026-08-06 | $190.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $21.20M 10-Q · filed 2026-05-08 | $78.96M derived: sum of 2 quarters · filed 2026-05-08 | $133.74M derived: sum of 3 quarters · filed 2026-05-08 | $193.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $57.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $112.54M derived: sum of 2 quarters · filed 2026-02-25 | $172.08M derived: sum of 3 quarters · filed 2026-08-06 | $599.64M 10-K · filed 2026-02-25 |
| 2025-09-30 | $54.78M 10-Q · filed 2025-11-06 | $114.31M derived: sum of 2 quarters · filed 2026-08-06 | $541.88M 10-Q · filed 2025-11-06 | $704.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $59.54M 10-Q · filed 2026-08-06 | $487.10M 10-Q · filed 2026-08-06 | $650.19M derived: sum of 3 quarters · filed 2026-08-06 | $724.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $427.56M 10-Q · filed 2026-05-08 | $590.65M derived: sum of 2 quarters · filed 2026-05-08 | $664.73M derived: sum of 3 quarters · filed 2026-05-08 | $846.51M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $163.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $237.17M derived: sum of 2 quarters · filed 2026-02-25 | $418.95M derived: sum of 3 quarters · filed 2026-02-25 | $511.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | $74.08M 10-Q · filed 2025-11-06 | $255.87M derived: sum of 2 quarters · filed 2025-11-06 | $348.51M 10-Q · filed 2025-11-06 | $445.63M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $181.78M 10-Q · filed 2025-08-07 | $274.43M 10-Q · filed 2025-08-07 | $371.55M derived: sum of 3 quarters · filed 2026-02-25 | $471.94M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $92.64M 10-Q · filed 2025-05-12 | $189.76M derived: sum of 2 quarters · filed 2026-02-25 | $290.16M derived: sum of 3 quarters · filed 2026-02-25 | $378.88M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $97.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $197.51M derived: sum of 2 quarters · filed 2026-02-25 | $286.23M derived: sum of 3 quarters · filed 2026-02-25 | $387.25M 10-K · filed 2026-02-25 |
| 2023-09-30 | $100.39M 10-Q · filed 2024-11-12 | $189.12M derived: sum of 2 quarters · filed 2024-11-12 | $290.13M 10-Q · filed 2024-11-12 | $382.35M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $88.72M 10-Q · filed 2024-08-09 | $189.73M 10-Q · filed 2024-08-09 | $281.96M derived: sum of 3 quarters · filed 2025-03-17 | $370.13M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $101.01M 10-Q · filed 2024-05-09 | $193.24M derived: sum of 2 quarters · filed 2025-03-17 | $281.40M derived: sum of 3 quarters · filed 2025-03-17 | $365.57M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $92.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $180.39M derived: sum of 2 quarters · filed 2025-03-17 | $264.55M derived: sum of 3 quarters · filed 2025-03-17 | $356.23M 10-K · filed 2025-03-17 |
| 2022-09-30 | $88.17M 10-Q · filed 2023-11-03 | $172.33M derived: sum of 2 quarters · filed 2023-11-03 | $264.01M 10-Q · filed 2023-11-03 | $345.45M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $84.16M 10-Q · filed 2023-08-04 | $175.84M 10-Q · filed 2023-08-04 | $257.28M derived: sum of 3 quarters · filed 2024-02-28 | $347.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $91.68M 10-Q · filed 2023-05-04 | $173.12M derived: sum of 2 quarters · filed 2024-02-28 | $262.96M derived: sum of 3 quarters · filed 2024-02-28 | $314.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $81.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $171.28M derived: sum of 2 quarters · filed 2024-02-28 | $222.61M derived: sum of 3 quarters · filed 2024-02-28 | $269.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | $89.84M 10-Q · filed 2022-11-08 | $141.17M derived: sum of 2 quarters · filed 2022-11-08 | $187.85M 10-Q · filed 2022-11-08 | $223.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $51.33M 10-Q · filed 2022-08-08 | $98.01M 10-Q · filed 2022-08-08 | $133.39M derived: sum of 3 quarters · filed 2023-02-28 | $164.63M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $46.69M 10-Q · filed 2022-05-06 | $82.06M derived: sum of 2 quarters · filed 2023-02-28 | $113.30M derived: sum of 3 quarters · filed 2023-02-28 | $143.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $35.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $66.62M derived: sum of 2 quarters · filed 2023-02-28 | $96.75M derived: sum of 3 quarters · filed 2023-02-28 | $136.95M 10-K · filed 2023-02-28 |
| 2020-09-30 | $31.24M 10-Q · filed 2021-11-05 | $61.38M derived: sum of 2 quarters · filed 2021-11-05 | $101.57M 10-Q · filed 2021-11-05 | $132.42M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $30.14M 10-Q · filed 2021-08-06 | $70.33M 10-Q · filed 2021-08-06 | $101.18M derived: sum of 3 quarters · filed 2021-08-06 | $136.21M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $40.20M 10-Q · filed 2021-05-06 | $71.05M derived: sum of 2 quarters · filed 2021-05-06 | $106.07M derived: sum of 3 quarters · filed 2021-05-06 | $140.07M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $30.85M 10-K · filed 2020-02-28 | $65.88M derived: sum of 2 quarters · filed 2020-11-03 | $99.87M derived: sum of 3 quarters · filed 2020-11-03 | $135.12M 10-K · filed 2022-02-28 |
| 2019-09-30 | $35.03M 10-Q · filed 2020-11-03 | $69.02M derived: sum of 2 quarters · filed 2020-11-03 | $104.27M 10-Q · filed 2020-11-03 | $140.64M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $33.99M 10-Q · filed 2020-08-06 | $69.24M 10-Q · filed 2020-08-06 | $105.61M derived: sum of 3 quarters · filed 2020-08-06 | $133.47M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $35.25M 10-Q · filed 2020-05-08 | $71.62M derived: sum of 2 quarters · filed 2020-05-08 | $99.48M derived: sum of 3 quarters · filed 2020-05-08 | $130.09M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $36.37M 10-K · filed 2020-02-28 | $64.23M derived: sum of 2 quarters · filed 2020-02-28 | $94.84M derived: sum of 3 quarters · filed 2020-02-28 | $126.08M 10-K · filed 2021-02-26 |
| 2018-09-30 | $27.86M 10-K · filed 2020-02-28 | $58.47M derived: sum of 2 quarters · filed 2020-02-28 | $89.71M 10-Q · filed 2019-11-07 | $119.74M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $30.61M 10-K · filed 2020-02-28 | $61.85M 10-Q · filed 2019-08-06 | $91.88M derived: sum of 3 quarters · filed 2020-02-28 | $121.67M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $31.25M 10-K · filed 2020-02-28 | $61.27M derived: sum of 2 quarters · filed 2020-02-28 | $91.06M derived: sum of 3 quarters · filed 2020-02-28 | $123.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $30.02M 10-K · filed 2019-02-26 | $59.82M derived: sum of 2 quarters · filed 2019-02-26 | $92.21M derived: sum of 3 quarters · filed 2019-02-26 | $124.44M 10-K · filed 2020-02-28 |
| 2017-09-30 | $29.80M 10-K · filed 2019-02-26 | $62.18M derived: sum of 2 quarters · filed 2019-02-26 | $94.42M 10-Q · filed 2018-11-05 | $123.67M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $32.39M 10-K · filed 2019-02-26 | $64.62M 10-Q · filed 2018-08-03 | $93.87M derived: sum of 3 quarters · filed 2019-02-26 | $123.25M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $32.24M 10-K · filed 2019-02-26 | $61.48M derived: sum of 2 quarters · filed 2019-02-26 | $90.86M derived: sum of 3 quarters · filed 2019-02-26 | $119.57M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $29.25M 10-K · filed 2018-02-26 | $58.62M derived: sum of 2 quarters · filed 2018-02-26 | $87.33M derived: sum of 3 quarters · filed 2018-02-26 | $115.40M 10-K · filed 2019-02-26 |
| 2016-09-30 | $29.37M 10-K · filed 2018-02-26 | $58.09M derived: sum of 2 quarters · filed 2018-02-26 | $86.16M 10-Q · filed 2017-11-02 | $113.68M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $28.71M 10-K · filed 2018-02-26 | $56.78M 10-Q · filed 2017-08-02 | $84.31M derived: sum of 3 quarters · filed 2018-02-26 | $88.25M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $28.07M 10-K · filed 2018-02-26 | $55.60M derived: sum of 2 quarters · filed 2018-02-26 | $59.53M derived: sum of 3 quarters · filed 2018-02-26 | $85.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $27.53M 10-K · filed 2017-03-06 | $31.46M derived: sum of 2 quarters · filed 2017-03-06 | $57.33M derived: sum of 3 quarters · filed 2017-03-06 | $82.58M 10-K · filed 2018-02-26 |
| 2015-09-30 | $3.94M 10-K · filed 2017-03-06 | $29.80M derived: sum of 2 quarters · filed 2017-03-06 | $55.06M 10-Q · filed 2016-11-04 | $77.39M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $25.86M 10-K · filed 2017-03-06 | $51.12M 10-Q · filed 2016-08-04 | $73.45M derived: sum of 3 quarters · filed 2017-03-06 | $95.03M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $25.25M 10-K · filed 2017-03-06 | $47.59M derived: sum of 2 quarters · filed 2017-03-06 | $69.16M derived: sum of 3 quarters · filed 2017-03-06 | $90.59M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $22.33M 10-K · filed 2016-03-11 | $43.91M derived: sum of 2 quarters · filed 2016-03-11 | $65.33M derived: sum of 3 quarters · filed 2016-03-11 | $86.26M 10-K · filed 2017-03-06 |
| 2014-09-30 | $21.57M 10-K · filed 2016-03-11 | $43.00M derived: sum of 2 quarters · filed 2016-03-11 | $63.92M 10-Q · filed 2015-11-05 | $84.12M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $21.43M 10-K · filed 2016-03-11 | $42.35M 10-Q · filed 2015-08-05 | $62.54M derived: sum of 3 quarters · filed 2016-03-11 | $83.72M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $20.92M 10-K · filed 2016-03-11 | $41.11M derived: sum of 2 quarters · filed 2016-03-11 | $62.29M derived: sum of 3 quarters · filed 2016-03-11 | $83.35M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $20.19M 10-K · filed 2015-03-12 | $41.37M derived: sum of 2 quarters · filed 2015-03-12 | $62.42M derived: sum of 3 quarters · filed 2015-03-12 | $83.96M 10-K · filed 2016-03-11 |
| 2013-09-30 | $21.18M 10-K · filed 2015-03-12 | $42.23M derived: sum of 2 quarters · filed 2015-03-12 | $63.77M 10-Q · filed 2014-11-05 | $86.09M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $21.06M 10-K · filed 2015-03-12 | $42.59M 10-Q · filed 2014-08-05 | $64.91M derived: sum of 3 quarters · filed 2015-03-12 | $87.68M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $21.54M 10-K · filed 2015-03-12 | $43.86M derived: sum of 2 quarters · filed 2015-03-12 | $66.63M derived: sum of 3 quarters · filed 2015-03-12 | $89.46M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $22.32M 10-K · filed 2014-03-14 | $45.09M derived: sum of 2 quarters · filed 2014-03-14 | $67.92M derived: sum of 3 quarters · filed 2014-03-14 | $95.28M 10-K · filed 2015-03-12 |
| 2012-09-30 | $22.77M 10-K · filed 2014-03-14 | $45.60M derived: sum of 2 quarters · filed 2014-03-14 | $72.96M 10-Q · filed 2013-11-12 | $97.18M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $22.83M 10-K · filed 2014-03-14 | $50.19M 10-Q · filed 2013-08-09 | $74.41M derived: sum of 3 quarters · filed 2014-03-14 | $107.18M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $27.36M 10-K · filed 2014-03-14 | $51.58M derived: sum of 2 quarters · filed 2014-03-14 | $84.35M derived: sum of 3 quarters · filed 2014-03-14 | $114.91M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $56.99M derived: sum of 2 quarters · filed 2014-03-14 | $87.55M derived: sum of 3 quarters · filed 2014-03-14 | $122.79M 10-K · filed 2014-03-14 |
| 2011-09-30 | $32.77M 10-Q · filed 2012-11-01 | $63.33M derived: sum of 2 quarters · filed 2012-11-01 | $98.56M 10-Q · filed 2012-11-01 | $135.43M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $30.56M 10-Q · filed 2012-08-07 | $65.80M 10-Q · filed 2012-08-07 | $102.67M derived: sum of 3 quarters · filed 2013-03-15 | $143.58M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $35.24M 10-Q · filed 2012-05-07 | $72.11M derived: sum of 2 quarters · filed 2013-03-15 | $113.02M derived: sum of 3 quarters · filed 2013-03-15 | $146.33M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $36.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $77.78M derived: sum of 2 quarters · filed 2013-03-15 | $111.09M derived: sum of 3 quarters · filed 2013-03-15 | $141.91M 10-K · filed 2013-03-15 |
| 2010-09-30 | $40.92M 10-Q · filed 2011-11-14 | $74.22M derived: sum of 2 quarters · filed 2011-11-14 | $105.04M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $33.30M 10-Q · filed 2011-08-12 | $64.12M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $88.20M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |